Suven Life Sciences LtdHealthcare Research- Analytics and TechnologyINE495B01038Consolidated₹341.55-8.30 (-2.37%)Jun-26
Valuation
Market Cap₹9.65K Cr
TTM PE-22.94x
Forward PE-22.45x
PEG-1.15
Book Value₹20.93
P/B16.32x
TTM EPS₹-14.89
Fwd EPS₹-15.21
TTM Revenue₹8.82 Cr
TTM PAT₹-352.44 Cr
TTM EBITDA₹-366.24 Cr
TTM EBIT₹-372.65 Cr
Last Qtr PAT₹-127.61 Cr
Last Qtr EBITDA₹-132.49 Cr
Last Qtr EBIT₹-134.65 Cr
Profitability
ROE-59.59%
ROCE-28.37%
TTM NPM-3995.92%
TTM EBITDA %-4152.38%
Curr OPM-1150.68%
Last OPM-549.40%
Curr NPM
Last NPM
Curr EPS₹-4.84
Last EPS₹-2.02
Balance sheet
Equity₹26.37 Cr
Reserve₹565.03 Cr
Total Debt₹16.93 Cr
D/E0.03x
Interest %-0.38%
Curr Interest₹0.48 Cr
Price / range
Close₹341.55
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D-2.37%
1W-3.94%
1M+0.49%
3M+31.52%
6M+147.68%
1Y+56.03%
2Y+119.01%
3Y+359.63%
5Y+296.46%
Diwali+106.81%
Sector peers — Healthcare Research- Analytics and Technology
CompanyCloseMkt CapTTM P/EROE
SYNGENE369.05₹14.90K Cr67.104.57%
INDGN600.10₹14.46K Cr35.9112.77%
SUVEN341.55₹9.65K Cr-22.94-59.59%
VIMTALABS603.10₹2.69K Cr22.6213.43%
BI109.14₹256.97 Cr-22.32
TAKE15.96₹236.10 Cr40.9241.35%
JSTL81.25₹161.84 Cr-49.85

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue3.57+90.9%1.522.810.921.877.11
Other Income7.526.782.773.780.5913.91
Total Income11.09+350.8%8.305.584.702.4621.03
Interest0.480.160000.16
Expenditure-27.21-57.9%-19.47-19.05-20.14-17.23-75.89
PBDT000000
EBITDA-21-50.1%-16.21-14.89-17.90-13.99-63.01
Depreciation-2.16-1.58-1.35-1.32-1.37-5.61
EBIT-23.16-50.8%-17.79-16.24-19.22-15.36-68.62
PBT-16.12-9.1%-11.17-13.47-15.45-14.78-54.86
Tax000000
Equity26.4026.370021.8126.37
OPM-145.36-134.58-479.60-1680.63-600.81-260.94
Net Profit-16.12-9.1%-11.17-13.47-15.45-14.78-54.86
NPM-145.36-134.58-479.60-1680.63-600.81-260.94
EPS-0.61+10.3%-0.50-0.60-0.70-0.680

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue7.11+6.8%6.66-43.0%11.69-13.7%13.54+14.4%11.84-12.2%13.48
Other Income13.9110.7321.138.455.327.75
Total Income21.03+21.0%17.38-47.0%32.82+49.2%21.99+28.1%17.16-19.2%21.23
Expenditure-75.89-17.7%-64.46-30.8%-49.29-2.4%-48.12+9.9%-53.41-8.6%-49.19
Interest-0.16-0.05-0.16-0.29-0.53-0.82
PBDT000000
EBITDA-63.01-21.3%-51.93-67.8%-30.94-11.5%-27.75+24.3%-36.65-20.0%-30.54
Depreciation-5.61-5.82-6.50-6.54-4.39-4.35
EBIT-68.62-18.8%-57.75-54.2%-37.44-9.2%-34.29+16.4%-41.04-17.6%-34.89
PBT-54.86-16.5%-47.08-422.5%-9.01+55.2%-20.13+44.5%-36.25-29.6%-27.96
Tax001005.32
Equity26.3721.810000
OPM (%)-260.94-270.86-27.00-92.00-211.00-132.00
Net Profit-54.86-16.5%-47.08-487.8%-8.01+60.2%-20.13+44.5%-36.25-60.2%-22.63
NPM (%)-260.94-270.86-24.00-92.00-211.00-107.00
EPS (Rs)00+100.0%-0.37+67.3%-1.13+60.2%-2.84-59.6%-1.78
CEPS00-0.37-1.13-2.84-1.78

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue3.57+90.9%1.522.810.921.877.11
Other Income7.526.782.783.780.6013.93
Total Income11.09+349.0%8.305.584.702.4721.04
Interest0.480.160000.16
Expenditure-138.70-156.9%-53.89-107.51-82.01-53.98-297.39
PBDT000000
EBITDA-132.49-161.1%-50.63-103.35-79.77-50.74-284.51
Depreciation-2.16-1.58-1.35-1.32-1.37-5.61
EBIT-134.65-158.4%-52.21-104.70-81.09-52.11-290.12
PBT-127.61-147.7%-45.6000-51.52-276.34
Tax000000
Equity26.4026.370021.8126.37
OPM-1150.68-549.400.000.00-2085.83-1313.12
Net Profit-127.61-147.7%-45.60-101.92-77.31-51.52-276.34
NPM-1150.68-549.40-1825.58-1645.94-2085.83-1313.12
EPS-4.84-105.1%-2.02-4.55-3.48-2.360

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue7.11+6.9%6.66-43.1%11.69-13.7%13.54+14.4%11.84-12.2%13.48
Other Income13.9310.9021.138.455.327.75
Total Income21.04+19.9%17.55-46.5%32.82+49.2%21.99+28.1%17.16-19.2%21.23
Expenditure-297.39-66.8%-178.30-21.8%-146.36-0.1%-146.26-5.1%-139.16-41.0%-98.71
Interest-0.16-0.05-0.16-0.29-0.53-0.82
PBDT000000
EBITDA-284.51-71.6%-165.77-29.5%-128.01-1.7%-125.89-2.9%-122.40-52.9%-80.06
Depreciation-5.61-5.82-6.50-6.54-4.39-4.35
EBIT-290.12-69.1%-171.59-27.6%-134.51-1.6%-132.43-4.4%-126.79-50.2%-84.41
PBT-276.34-71.9%-160.75-51.5%-106.08+10.3%-118.27+3.1%-122-57.5%-77.47
Tax001005.32
Equity26.3721.820000
OPM (%)-1313.12-915.79-323.18-537.88-710.89-364.89
Net Profit-276.34-71.9%-160.75-53.0%-105.08+11.2%-118.27+3.1%-122-69.1%-72.15
NPM (%)-1313.12-915.79-320.13-537.88-710.89-339.82
EPS (Rs)00+100.0%-4.82+27.3%-6.63+30.7%-9.57-68.8%-5.67
CEPS00-4.82-6.63-9.57-5.67

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

16
YearTypeAmountEx-Date
2019Interim Dividend1.514 Feb 2019
2018Interim Dividend1.506 Feb 2018
2017Interim Dividend108 Feb 2017
2016Interim Dividend114 Mar 2016
2016Special Dividend114 Mar 2016
2015Final Dividend0.623 Jul 2015
2014Final Dividend0.524 Jul 2014
2014Final Dividend0.524 Jul 2014
2014Special Dividend224 Jul 2014
2014Special Dividend224 Jul 2014
2013Final Dividend0.301 Aug 2013
2012Final Dividend0.317 Sep 2012
2011Final Dividend0.2501 Aug 2011
2010Final Dividend0.2519 Jul 2010
2009Final Dividend0.2514 Sep 2009
2008Final Dividend0.2511 Sep 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers